Holen Sie sich die Stockscreener-App
0.782
0.41%
-0.0032
Schlusskurs vom Vortag:
$0.7852
Offen:
$0.77
24-Stunden-Volumen:
13,657
Relative Volume:
0.11
Marktkapitalisierung:
$6.37M
Einnahmen:
$431.40K
Nettoeinkommen (Verlust:
$-1.95M
KGV:
-6.3166
EPS:
-0.1238
Netto-Cashflow:
$-726.80K
1W Leistung:
-2.49%
1M Leistung:
-13.48%
6M Leistung:
-25.52%
1J Leistung:
-15.91%
1-Tages-Spanne:
$0.77
$0.793
1-Wochen-Bereich:
$0.77
$0.8298
52-Wochen-Spanne:
$0.65
$4.47
Aptorum Group Ltd Stock (APM) Company Profile
Firmenname
Aptorum Group Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare APM vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APM
Aptorum Group Ltd
|
0.782 | 6.37M | 431.40K | -1.95M | -726.80K | -0.1238 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aptorum Group Ltd Aktie (APM) Neueste Nachrichten
APM Should I Buy - Intellectia AI
Aptorum-backed DiamiR expands Alzheimer’s diagnostic efforts - Longevity.Technology
Aptorum Group Ltd (APM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 6K Aptorum Group Ltd For: 22 June By Investing.com - Investing.com South Africa
Press Release: Aptorum Group Announces Collaboration Between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - Moomoo
Aptorum | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment) - Moomoo
Aptorum Group Ltd (APM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aptorum Group Ltd (APM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aptorum Group Ltd (APM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aptorum Group Ltd (APM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aptorum Group Ltd (APM) Institutional Confidence - TradingKey
Aptorum Group Ltd (APM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aptorum Group Ltd (APM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aptorum Group Ltd (APM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PULM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
APM News | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Aptorum Shareholders Approve Proposed Merger With DiamiR Biosciences - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Aptorum Group Limited Announces Board of Directors Appointments - marketscreener.com
Aptorum shareholders approve merger with DiamiR Biosciences By Investing.com - Investing.com South Africa
Aptorum Group Limited and DiamiR Biosciences Corp. Shareholders Approve Merger Transaction - Quiver Quantitative
Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - Yahoo Finance
APMAptorum Group Ltd Stock Price and Quote - Finviz
Aptorum Group Limited (APM) Hovers Near Support at $0.80 After Marginal DeclinePut Spread Alert - newsline.com
APM | Aptorum Group Limited Class Insider Trading - Quiver Quantitative
APM Technical Analysis | Trend, Signals & Chart Patterns | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Why Is Aptorum Group Limited (APM.PA) Stock Down Today? - Meyka
RVPH Stock Price and Chart — OTC:RVPH - TradingView
Aptorum | EFFECT: Others - Moomoo
TradingKey - TradingKey
Aptorum | S-4/A: Registration of securities issued in business combination transactions (Amendment) - Moomoo
Aptorum Group to Domesticate, Merge with DiamiR (NASDAQ: APM) - Stock Titan
Is Aptorum (APM) stock considered high volatility (Slight Gain) 2026-04-22Swing Trade - newser.com
Can Aptorum (APM) Stock Double in 2026 | Price at $0.93, Up 0.29%Continuation Pattern - Newser
XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI
APRE PE Ratio & Valuation, Is APRE Overvalued - Intellectia AI
APM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aptorum Group Soars Over 20% as Market Deciphers Regulatory Chaos and Sector Growth Signals - Bitget
DiamiR merger gives Aptorum (NASDAQ: APM) holders 30% of new Niki BioSolutions - stocktitan.net
Aptorum (NASDAQ: APM) to merge with DiamiR; domestication and share issuance - Stock Titan
Direxion Daily AMZN Bull 2X Shares (NASDAQ:AMZU) Short Interest Up 22.7% in March - Defense World
APTORUM GROUP PB Ratio: 0.29 | Possible Value Trap - GuruFocus
Going concern warning and high risk profile at Aptorum Group (NASDAQ: APM) - Stock Titan
Aptorum (NASDAQ: APM) delays DiamiR merger cutoff to June 30, 2026 - Stock Titan
If You Invested $1,000 in Aptorum Group Ltd (APM) - Stock Titan
Aptorum Group (APM) Stock Analysis Report | Financials & Insights - Benzinga Japan
[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC FilingForm 6-K - Stock Titan
Aptorum, DiamiR publish glioblastoma blood test study By Investing.com - Investing.com South Africa
Aptorum, DiamiR publish glioblastoma blood test study - Investing.com Nigeria
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - Bitget
Blood test study takes aim at glioblastoma, deadliest brain cancer - Stock Titan
Finanzdaten der Aptorum Group Ltd-Aktie (APM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):